Foodie. Hematologist/oncologist at @LAGeneralMed. Former @BCMHemeOnc chief fellow and @ucsdim chief resident. Proud Cal Bear (@UCBerkeley) for life.
Los Angeles, CA
Joined June 2009
- Tweets21
- Following78
- Followers50
- Likes31
In a cohort of pts with classical Hodgkin lymphoma enriched in advanced-stage, higher-risk, and HIV-associated disease and treated at @harrishealth, uninsurance was not associated with inferior outcomes. authors.elsevier.com/a/1lm85… @AngLi_MD @ChrisRFlowersMD @BCMHemeOnc
Mark Jiang retweeted
Tired of spending all day chart-reviewing to find acute venous #thrombosis (PE/DVT)?
Try our validated VTE-BERT, a fine-tuned #NLP #AI model that extracts #VTE outcomes from full clinical notes.
🔗 nlpmed.demo.angli-lab.com/
📄 doi.org/10.1016/j.jtha.2025.…
@JTHjournal @BCMDeptMedicine
In our systematic review, we found persistent disparities in enrollment rates into lymphoma trials related to age, sex, gender, race, ethnicity, geography, and SES. academic.oup.com/oncolo/adva… @AngLi_MD @ChrisRFlowersMD @BCMHemeOnc
ctDNA is an underexplored tool for the prognostication of cancer-associated VTE. The # of pathogenic ctDNA mutations is independently predictive of VTE risk. sciencedirect.com/science/ar… @JTHjournal @AngLi_MD @BCMHemeOnc
That moment when you got a lot more malignant heme in you than you thought and end up getting a cake reminiscent of leukemia blasts... Happy birthday to our phenomenal PD, Dr. Miller-Chism! @BCMHemeOnc
Problem representations don't go away in fellowship! Practicing clinical reasoning with the med studs. #MedEd @BCMHemeOnc – at Houston, TX
Hot off the press! Survival of large B-cell lymphoma pts treated at @harrishealth, a safety-net health system with robust financial assistance, was comparable to SEER estimates. R-IPI remains prognostic: doi.org/10.1016/j.bneo.2024.…. @AngLi_MD @ChrisRFlowersMD @BCMHemeOnc
Mark Jiang retweeted
It's true that we just said goodbye to our graduating fellows, but we also welcomed a new wonderful class of 11 fellows! Excited to see how these bright minds make cancer history. Say hi to the Class of 2027! @bcmhouston
Mark Jiang retweeted
Heme/Onc fellows, I'm doing a MedEd project to help improve training on clinical trials & drug dev. Please fill out this anonymous 5-min survey to assess resources & gaps in fellowship training on this important topic! #MedTwitter #onctwitter forms.gle/Z3vnYSPRdo29RvUc9
Here's an anticoagulation cheat sheet for those who find it helpful. For everything else, your friendly neighborhood hematologist is here to help! @BCMHemeOnc #BloodClots #MedTwitter
Mark Jiang retweeted
A big congratulations to our two new rising chief fellows @DrKaylaMiranda and @markjyjiang . We are very excited to have them to join the leadership of the fellowship program next academic year.
Proud to be part of the team that brought you this study highlighting the natural history of #cancer-associated splanchnic vein #thrombosis, a poorly understood disease entity with a distinct clinical behavior from usual-site #VTE. @BCMHemeOnc
Anticoagulation in #cancer-associated splanchnic vein #thrombosis (SpVT) requires judicious consideration for thrombotic & bleeding risk.
This study by Shang et al. delves deeper into the natural history & management of SpVT. @AngLi_MD
jthjournal.org/article/S1538… @ELShematology
Mark Jiang retweeted
Congratulations to our ⭐️ fellow Dr. Mark Jiang ( @magicindark) for winning the ASH Abstract Achievement Award for his very important work on the clinical outcomes of LBCL in the undeserved population. #ASH23
Mark Jiang retweeted
We are live from #ASH23 with PGY5 @Ibrahematology @magicindark and Michael Bruce and PGY6 @mt_sidd and Elizabeth Eisenmenger, having fun and busy attending sessions on smoldering and newly diagnosed multiple myeloma and R/R large B cell lymphoma outcomes.
